Tildrakizumab – March 2026

Injection 100 mg in 1 mL single dose pre-filled syringe

  • Brand names:
    • Ilumya®
  • Pharmaceutical Company:
    • SUN PHARMA ANZ PTY LTD
  • Condition/Indication: Severe chronic plaque psoriasis
  • Meeting Date: March 2026
Public Summary Documents
Last updated
11 March 2026